Fighting the good fight: The role of militaries in malaria elimination in Southeast Asia

Trends in Parasitology

Volumn 30, Issue 12, 2014, Pages 571-581

  Manning, Jessica E ^a   Satharath, Prom ^b   Gaywee, Jariyanart ^c   Lopez, Maria Nila ^d   Lon, Chanthap ^a,e   Saunders, David L ^a  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b Royal Cambodian Armed Forces   (Cambodia)

^c Royal Thai Army   (Thailand)

^d Armed Forces of the Philippines   (Philippines)

^e Armed Forces Research Institute of Medical Sciences   (Cambodia)

Author keywords

Malaria elimination; Military; Southeast Asia

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMISININ; ARTESUNATE; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; DIHYDROARTEMISININ; MEFLOQUINE; NAPHTHOQUINONE; PIPERAQUINE; PRIMAQUINE; PROGUANIL; PYRONARIDINE;

ARMY; CAMBODIA; DONOR; FUNDING; HUMAN; MALARIA; MALARIA CONTROL; MEDICAL RESEARCH; PARASITE; PHILIPPINES; POLITICS; POPULATION; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOLDIER; SOUTHEAST ASIA; THAILAND; VECTOR CONTROL; ANIMAL; DISEASE CARRIER; DISEASE ERADICATION; MOSQUITO; PARASITOLOGY; TRANSMISSION;

ANIMALS; ASIA, SOUTHEASTERN; CULICIDAE; DISEASE ERADICATION; DISEASE RESERVOIRS; HUMANS; MALARIA; MILITARY PERSONNEL;

EID: 84922778468     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2014.10.002     Document Type: Review

References (89)

1. Bhatia R., et al. Malaria successes and challenges in Asia. J. Vector Borne Dis. 2013, 50:239-247.
2. Newton P., et al. Fake artesunate in Southeast Asia. Lancet 2001, 357:1948-1950.
3. Delacollette C., et al. Malaria trends and challenges in the Greater Mekong Subregion. Southeast Asian J. Trop. Med. Public Health 2009, 40:674-691.
4. Kritsiriwuthinan K., Ngrenngarmlert W. Molecular screening of Plasmodium infections among migrant workers in Thailand. J. Vector Borne Dis. 2011, 48:214-218.
5. Carrara V.I., et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med. 2013, 10:e1001398.
6. Wangroongsarb P., et al. Characteristics and malaria prevalence of migrant populations in malaria-endemic areas along the Thai-Cambodian border. Southeast Asian J. Trop. Med. Public Health 2012, 43:261-269.
7. Smith C., Whittaker M. Beyond mobile populations: a critical review of the literature on malaria and population mobility and suggestions for future directions. Malar. J. 2014, 13:307.
8. Ariey F., et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014, 505:50-55.
9. World Health Organization Global Plan for Artemisinin Resistance Containment 2011, WHO.
10. World Health Organization Update on Artemisinin Resistance - January 2014 2014, WHO.
11. Gueye C.S., et al. The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong subregion. Malar. J. 2014, 13:286.
12. Cambodian Ministry of Health, National Strategic Plan for Elimination of Malaria in the Kingdom of Cambodia 2011-2025, Cambodian Ministry of Health.
13. Pindolia D.K., et al. Quantifying cross-border movements and migrations for guiding the strategic planning of malaria control and elimination. Malar. J. 2014, 13:169.
14. Bhumiratana A., et al. Border malaria associated with multidrug resistance on Thailand-Myanmar and Thailand-Cambodia borders: transmission dynamic, vulnerability, and surveillance. BioMed Res. Int. 2013, 2013:e363417.
15. Association of Southeast Asian Nations ASEAN Economic Community Blueprint 2008, ASEAN Secretariat.
16. World Health Organization Lao PDR: Malaria Outbreaks Remain Worrisome but Progress is Being Made in Response and Control 2014, WHO.
17. UCSF Global Health Group and Department of Health Philippines, Eliminating Malaria in the Philippines 2012, UCSF.
18. Premaratna R., et al. What clinicians who practice in countries reaching malaria elimination should be aware of: lessons learnt from recent experience in Sri Lanka. Malar. J. 2011, 10:302.
19. Sutanto I., et al. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob. Agents Chemother. 2013, 57:1128-1135.
20. United Nations United Nations Peacekeeping. Troop and Police Contributors. Data Dashboard 2014, UN.
21. Juliao P.C., et al. Importation of chloroquine-resistant Plasmodium falciparum by Guatemalan peacekeepers returning from the Democratic Republic of the Congo. Malar. J. 2013, 12:344.
22. Patel J.C., et al. Genetic evidence of importation of drug-resistant Plasmodium falciparum to Guatemala from the Democratic Republic of the Congo. Emerg. Infect. Dis. 2014, 20:932-940.
23. United Nations Manual on Policies and Procedures Concerning the Reimbursement and Control of Contingent-Owned Equipment of Troop/Police Contributors Participating in Peacekeeping Missions (COE Manual) 2011, UN.
24. United Nations Medical Support Manual for United Nations Peacekeeping Operations 1999, UN. 2nd edn.
25. Schwartz E., et al. Malaria antibodies and mefloquine levels among United Nations troops in Angola. J. Travel Med. 2001, 8:113-116.
26. Hewitt S., et al. Malaria situation in the Greater Mekong Subregion. Southeast Asian J. Trop. Med. Public Health 2013, 44(Suppl. 1):46-72. discussion 306-307.
27. Lon C., et al. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial. PLoS ONE 2014, 9:e93138.
28. Lin J.T., et al. The role of submicroscopic parasitemia in malaria transmission: what is the evidence?. Trends Parasitol. 2014, 30:183-190.
29. Howes R.E., et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012, 9:e1001339.
30. Jitthai N. Migration and malaria. Southeast Asian J. Trop. Med. Public Health 2013, 44(Suppl. 1):166-200. discussion 306-307.
31. D'Alessandro U., Buttiëns H. History and importance of antimalarial drug resistance. Trop. Med. Int. Health 2001, 6:845-848.
32. Noedl H., et al. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 2008, 359:2619-2620.
33. Farooq U., Mahajan R.C. Drug resistance in malaria. J. Vector Borne Dis. 2004, 41:45-53.
34. Wongsrichanalai C., Sibley C.H. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance. Clin. Microbiol. Infect. 2013, 19:908-916.
35. Bustos M.D., et al. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010. Southeast Asian J. Trop. Med. Public Health 2013, 44(Suppl. 1):201-230. discussion 306-307.
36. Kolaczinski J., et al. Vector control to eliminate artemisinin resistant malaria in the Greater Mekong Subregion. Lancet Infect. Dis. 2014, 14:9-11.
37. Suwonkerd W., et al. Vector biology and malaria transmission in southeast Asia. Anopheles Mosquitoes - New Insights into Malaria Vectors 2013, InTech. S. Manguin (Ed.).
38. Food and Agriculture Organization (FAO) of the United Nations Southeast Asian Forests and Forestry to 2020: Subregional Report of The Second Asia-Pacific Forestry Sector Outlook Study 2010, UN.
39. Malaria Consortium Report of Greater Mekong Subregion Operational Research Symposium 2010, Malaria Consortium.
40. Presidential Malaria Initiative President's Malaria Initiative Malaria Operational Plan - FY 2012: Greater Mekong Subregion 2012, Presidential Malaria Initiative.
41. Sochantha T., et al. Personal protection by long-lasting insecticidal hammocks against the bites of forest malaria vectors. Trop. Med. Int. Health 2010, 15:336-341.
42. Soto J., et al. Efficacy of permethrin-impregnated uniforms in the prevention of malaria and leishmaniasis in Colombian soldiers. Clin. Infect. Dis. 1995, 21:599-602.
43. Kimani E.W., et al. Use of insecticide-treated clothes for personal protection against malaria: a community trial. Malar. J. 2006, 5:63.
44. Vanwambeke S.O., et al. Impact of land-use change on dengue and malaria in northern Thailand. EcoHealth 2007, 4:37-51.
45. Lee V.J., et al. Elimination of malaria risk through integrated combination strategies in a tropical military training island. Am. J. Trop. Med. Hyg. 2010, 82:1024-1029.
46. World Health Organization Global Malaria Programme Emergency Response to Artemisinin Resistance in the Greater Mekong Subregion: Regional Framework for Action 2013-2015 2013, WHO.
47. UCSF Global Health Group and CEPA Financing for Malaria Elimination 2013, UCSF Global Health Group.
48. World Health Organization Global Malaria Programme World Malaria Report 2013 2013, WHO.
49. Centre Nationale de Malariologie Cambodia Malaria Bulletin: December 2013 2013, Centre Nationale de Malariologie.
50. Saunders D.L., et al. Dihydroartemisinin-piperaquine failure in Cambodia. N. Engl. J. Med. 2014, 371:484-485.
51. Leang R., et al. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob. Agents Chemother. 2013, 57:818-826.
52. Manning J., et al. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern of prolonged QTc interval. Antimicrob. Agents Chemother. 2014, 58:6056-6067.
53. Ministry of Health, Cambodia Health Strategic Plan, 2008-2015 2008, Ministry of Health, Cambodia.
54. World Health Organization Global Malaria Programme World Malaria Report 2011 2011, WHO.
55. Carrara V.I., et al. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. PLoS Med. 2006, 3:e183.
56. Khamsiriwatchara A., et al. Respondent-driven sampling on the Thailand-Cambodia border. I. Can malaria cases be contained in mobile migrant workers?. Malar. J. 2011, 10:120.
57. Wangroongsarb P., et al. Respondent-driven sampling on the Thailand-Cambodia border. II. Knowledge, perception, practice and treatment-seeking behaviour of migrants in malaria endemic zones. Malar. J. 2011, 10:117.
58. Department of Health, Philippines The Philippines is on the verge of attaining malaria-free status. Official Gazette 2014, 11 March.
59. Liu J.X., et al. Determinants of malaria program expenditures during elimination: case study evidence from select provinces in the Philippines. PLoS ONE 2013, 8:e73352.
60. Asia Pacific Malaria Elimination Network Philippines Malaria Control Program 2011, APMEN.
61. The Global Health Group and the Malaria Atlas Project Atlas of Malaria-eliminating Countries, 2011 2011, The Global Health Group.
62. Alam M.S., et al. Real-time PCR assay and rapid diagnostic tests for the diagnosis of clinically suspected malaria patients in Bangladesh. Malar. J. 2011, 10:175.
63. Okell L.C., et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat. Commun. 2012, 3:1237.
64. Patel J.C., et al. Field evaluation of a real-time fluorescence loop-mediated isothermal amplification assay, REALAMP, for the diagnosis of malaria in Thailand and India. J. Infect. Dis. 2014, 210:1180-1187.
65. Sattabongkot J., et al. Loop-mediated isothermal amplification assay for rapid diagnosis of malaria infections in an area of endemicity in Thailand. J. Clin. Microbiol. 2014, 52:1471-1477.
66. von Seidlein L., et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar. J. 2013, 12:112.
67. Tinley K.E., et al. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am. J. Trop. Med. Hyg. 2010, 82:210-214.
68. TM G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE 2011, 6:e28357.
69. Urquia M.L., Gagnon A.J. Glossary: migration and health. J. Epidemiol. Community Health 2011, 65:467-472.
70. Wickramage K., et al. High attack rate for malaria through irregular migration routes to a country on verge of elimination. Malar. J. 2013, 12:276.
71. Saunders D., et al. US Department of Defense contributions to malaria surveillance. Lancet Infect. Dis. 2013, 13:293-294.
72. Zwang J., et al. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS ONE 2009, 4:e6358.
73. Krudsood S., et al. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 2007, 76:655-658.
74. Srivastava I.K., et al. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol. Microbiol. 1999, 33:704-711.
75. Tshefu A.K., et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet 2010, 375:1457-1467.
76. Duparc S., et al. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Malar. J. 2013, 12:70.
77. European Medicines Agency Annex I: Summary of Product Characteristics, Pyramax 2012, EMA.
78. Carrara V.I., et al. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS ONE 2009, 4:e4551.
79. Leang R., et al. Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia. Malar. J. 2013, 12:343.
80. Lim P., et al. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Antimicrob. Agents Chemother. 2010, 54:2135-2142.
81. Denis M.B., et al. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop. Med. Int. Health 2006, 11:1800-1807.
82. Song J., et al. Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area. Malar. J. 2011, 10:231.
83. Hombhanje F.W., Huang Q. Artemisinin-naphthoquine combination (ARCO®): an overview of the Progress. Pharmaceuticals 2010, 3:3581-3593.
84. Anthony M.P., et al. The global pipeline of new medicines for the control and elimination of malaria. Malar. J. 2012, 11:316.
85. Zwang J., et al. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009. Malar. J. 2014, 13:114.
86. Zwang J., et al. Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa. Malar. J. 2012, 11:260.
87. Pasaribu A.P., et al. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia. J. Infect. Dis. 2013, 208:1906-1913.
88. Smithuis F., et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect. Dis. 2010, 10:673-681.
89. Xia Z.G., et al. Malaria situation in the People's Republic of China in 2010. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2012, 30:419-422. (in Chinese).